Clinical trial data

Clinical trial data tracks interventional and observational studies from registration to results. Pharma competitive-intelligence teams, contract research organizations, site networks, investors and patient-recruitment companies use it to map pipelines, benchmark enrollment and choose sites.

Typical fields

• Trial identifier (NCT number or other registry ID) and title
• Sponsor and collaborators
• Phase, status, start and completion dates
• Condition, intervention and mechanism of action
• Target and actual enrollment
• Sites, countries and investigators where disclosed
• Primary endpoints and posted results

Sources and collection

Most datasets aggregate public registries such as ClinicalTrials.gov, the EU Clinical Trials Information System and the national registries linked through the WHO International Clinical Trials Registry Platform (ICTRP). Value-added providers normalize sponsor names, map conditions and drugs to standard vocabularies, merge trials registered in more than one registry, and add signals from press releases, conference abstracts and publications.

Delivery and pricing

Usually delivered as a searchable database, an API or periodic bulk files. Pricing is typically an annual subscription, scaled by therapeutic areas, number of users and whether curated fields such as outcomes, site performance and drug mapping are included.

Before you buy

• Check which registries are covered and how quickly new registrations appear.
• Ask how duplicate registrations across registries are merged.
• Confirm which code sets sponsor, condition and drug names are mapped to.
• Review how status changes, suspensions and terminations are captured over time.
• Check whether historical snapshots are kept, so you can see what was known on a given date.